Anti–PD-1–related pneumonitis during cancer immunotherapy
M Nishino, LM Sholl, H Hatabu… - New England Journal …, 2015 - Mass Medical Soc
M Nishino, LM Sholl, H Hatabu, NH Ramaiya, FS Hodi
New England Journal of Medicine, 2015•Mass Medical SocAnti–PD-1–Related Pneumonitis during Cancer Immunotherapy | NEJM Skip to main content
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
NEJM Group Follow Us Facebook Twitter Instagram YouTube LinkedIn Prepare to become a
physician, build your knowledge, lead a health care organization, and advance your career with
NEJM Group information and services. NEJM Evidence NEW! A digital journal for innovative
original research and fresh, bold ideas in clinical trial design and clinical decision-making.
NEJM Catalyst NEW! Peer-reviewed journal featuring in-depth articles to accelerate the …
Among three patients with melanoma receiving anti–PD-1 antibodies, the use of checkpoint blockers led to the development of serious autoimmune pneumonitis, a potentially lethal complication.
The New England Journal Of Medicine